More than a dozen lawsuits have been filed on behalf of weight-loss drug users who claim that popular weight-loss medications such as Ozempic have caused a loss of vision.
Patients from New York and New Jersey have claimed that they suffered non-arteritic anterior ischemic optic neuropathy after taking drugs containing semaglutide — the active ingredient in Ozempic, Wegovy and Rybelsus. The condition is rare and includes a loss of blood flow to the optic nerve that causes sudden vision loss in one eye.
